BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8228085)

  • 1. Spontaneous reactivation of chronic hepatitis B infection leading to fulminant hepatic failure. Report of two cases and review of the literature.
    Meyer RA; Duffy MC
    J Clin Gastroenterol; 1993 Oct; 17(3):231-4. PubMed ID: 8228085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Severe exacerbation of chronic hepatitis B following interferon therapy].
    Laskus T; Radkowski M; Cianciara J; Loch T; Slusarczyk J
    Wiad Lek; 1992 Jun; 45(11-12):458-61. PubMed ID: 1441531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients.
    Lee WC; Wu MJ; Cheng CH; Chen CH; Shu KH; Lian JD
    Am J Kidney Dis; 2001 Nov; 38(5):1074-81. PubMed ID: 11684562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fulminant hepatic failure and hepatitis B virus reactivation: case reports and analyses of the pathological mechanism].
    Tian Y; Gong G
    Zhonghua Gan Zang Bing Za Zhi; 2014 Apr; 22(4):272-6. PubMed ID: 25173225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
    Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
    Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of hepatitis B virus-infected recipients after orthotopic liver transplantation.
    König V; Hopf U; Neuhaus P; Bauditz J; Schmidt CA; Blumhardt G; Bechstein WO; Neuhaus R; Lobeck H
    Transplantation; 1994 Sep; 58(5):553-9. PubMed ID: 8091481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and molecular analysis of hepatitis B virus reactivation in hepatitis B surface antigen-negative patients during or after immunosuppressive or cytotoxic chemotherapy.
    Hayashi K; Ishigami M; Ishizu Y; Kuzuya T; Honda T; Tachi Y; Ishikawa T; Katano Y; Yoshioka K; Toyoda H; Kumada T; Goto H; Hirooka Y
    J Gastroenterol; 2016 Nov; 51(11):1081-1089. PubMed ID: 26943169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fulminant hepatitis after allogenic bone marrow transplantation caused by reactivation of hepatitis B virus with gene mutations in the core promotor region.
    Kitano K; Kobayashi H; Hanamura M; Furuta K; Ueno M; Rokuhara A; Tanaka E; Umemura T; Kiyosawa K
    Eur J Haematol; 2006 Sep; 77(3):255-8. PubMed ID: 16923112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired response to alpha interferon in patients with an inapparent hepatitis B and hepatitis C virus coinfection.
    Zignego AL; Fontana R; Puliti S; Barbagli S; Monti M; Careccia G; Giannelli F; Giannini C; Buzzelli G; Brunetto MR; Bonino F; Gentilini P
    Arch Virol; 1997; 142(3):535-44. PubMed ID: 9349299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: outcomes and predictors of response.
    Hope RL; Weltman M; Dingley J; Fiatarone J; Hope AH; Craig PI; Grierson JM; Bilous M; Williams SJ; Farrell GC
    Med J Aust; 1995 Jan; 162(1):8-11. PubMed ID: 7845310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of chronic hepatitis B with interferon alpha-2b].
    Baumgarten R; Müller R; Markus R; Hintsche-Kilger B; Fengler JD; Meisel H
    Gastroenterol J; 1990; 50(3):124-8. PubMed ID: 2288653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B and cancer: A practical guide for the oncologist.
    Bozza C; Cinausero M; Iacono D; Puglisi F
    Crit Rev Oncol Hematol; 2016 Feb; 98():137-46. PubMed ID: 26657667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon alfa-2b therapy in children with chronic hepatitis B.
    Sokal EM; Wirth S; Goyens P; Depreterre A; Cornu C
    Gut; 1993; 34(2 Suppl):S87-90. PubMed ID: 8314496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent and rapid emergence of mutated pre-C sequences in HBV from e-antigen positive carriers who seroconvert to anti-HBe during interferon treatment.
    Günther S; Meisel H; Reip A; Miska S; Krüger DH; Will H
    Virology; 1992 Mar; 187(1):271-9. PubMed ID: 1736529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: precore/core mutations may play an important role.
    Steinberg JL; Yeo W; Zhong S; Chan JY; Tam JS; Chan PK; Leung NW; Johnson PJ
    J Med Virol; 2000 Mar; 60(3):249-55. PubMed ID: 10630955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivation of hepatitis B virus infection induced by interferon (IFN) in HBsAg-positive, antiHCV-positive patients.
    Villa E; Grottola A; Trande P; Seium Y; Rebecchi AM; Dugani A; Manenti F
    Lancet; 1993 May; 341(8857):1413. PubMed ID: 7684479
    [No Abstract]   [Full Text] [Related]  

  • 17. [Reactivation of virus replication during immunosuppressive therapy in children with chronic hepatitis B].
    Giacchino R; Facco F; Loy A; Timitilli A; Cirillo C; Navone C; Ciravegna B; Pisani N
    Boll Ist Sieroter Milan; 1989; 68(1):24-7. PubMed ID: 2491283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low dose alpha interferon treatment in chronic hepatitis B virus infection.
    Müller R; Baumgarten R; Markus R; Schulz M; Wittenberg H; Hintsche-Kilger B; Fengler JD; von Wussow P; Meisel H; Klein H
    Gut; 1993; 34(2 Suppl):S97-8. PubMed ID: 8314499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nationwide prospective and retrospective surveys for hepatitis B virus reactivation during immunosuppressive therapies.
    Mochida S; Nakao M; Nakayama N; Uchida Y; Nagoshi S; Ido A; Mimura T; Harigai M; Kaneko H; Kobayashi H; Tsuchida T; Suzuki H; Ura N; Nakamura Y; Bessho M; Dan K; Kusumoto S; Sasaki Y; Fujii H; Suzuki F; Ikeda K; Yamamoto K; Takikawa H; Tsubouchi H; Mizokami M
    J Gastroenterol; 2016 Oct; 51(10):999-1010. PubMed ID: 26831356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C: a systematic review and meta-analysis.
    Mücke MM; Backus LI; Mücke VT; Coppola N; Preda CM; Yeh ML; Tang LSY; Belperio PS; Wilson EM; Yu ML; Zeuzem S; Herrmann E; Vermehren J
    Lancet Gastroenterol Hepatol; 2018 Mar; 3(3):172-180. PubMed ID: 29371017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.